Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-PSMA-11 Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of High Risk or Recurrent Prostate Cancer

NCT04484701 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT04484701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04484701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-PSMA-11 Positron Emission Tomography / Computed Tomography (PET/CT) for Assessment of High Risk or Recurrent Prostate Cancer
Lead sponsor
British Columbia Cancer Agency
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2021
Completion date
September 30, 2028
Enrollment
1,574 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic cancer, prostatic neoplasm